Lv5
1100 积分 2024-02-19 加入
Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies
4天前
已完结
Novel ROR1 inhibitor ARI-1 suppresses the development of non-small cell lung cancer
5天前
已完结
Development of Peptide Paratope Mimics Derived from the Anti-ROR1 Antibody and Long-Acting Peptide–Drug Conjugates for Targeted Cancer Therapy
5天前
已完结
Exploration of macrocyclic peptide binders to the extracellular CRD domain of human receptor tyrosine kinase-like orphan receptor 1 (ROR1)
6天前
已关闭
Radioligand theranostics in oncology: emerging trends in target design and radiochemical innovation
19天前
已完结
Structure-Based Design of a Novel Covalent 4-(1-Methylindol-3-yl)pyrimidin-2-amine Series Targeting FGFR2 Resistance Mutations
25天前
已完结
Radiobiological investigations of a [ 212 Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models
1个月前
已完结
Small Organic Carbonic Anhydrase IX Ligands from DNA-Encoded Chemical Libraries for Tumor-Targeted Delivery of Radionuclides
1个月前
已完结
Peptide receptor radionuclide therapy (PRRT) special issue
3个月前
已完结
A fast high-throughput logP estimation method for peptide molecules based on liquid chromatography-mass spectrometry method
3个月前
已完结
皖公网安备34019202002308
